Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 2/20 | 0.50 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.50 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.50 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.50 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | GJB2 | P29033 | 1/20 | 0.39 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | FGF1 | P05230 | 2/20 | 0.37 |
| ▸ | FGF2 | P09038 | 2/20 | 0.37 |
| ▸ | VEGFA | P15692 | 2/20 | 0.37 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16367561 | 1.00 | SSTR5 (0.50) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL15871629 | 0.96 | SSTR5 (0.51) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL2621331 | 0.96 | SSTR5 (0.51) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL412334 | 0.96 | SSTR5 (0.51) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL14999636 | 0.96 | SSTR5 (0.51) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL15502120 | 0.96 | SSTR5 (0.51) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL11921409 | 0.96 | SSTR5 (0.51) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL14370515 | 0.92 | SSTR1 (0.53) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL15504369 | 0.92 | FGF1 (0.43) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL18328600 | 0.92 | FGF1 (0.43) | SSTR5SSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291646-A1 | METHOD OF PREPARATION OF ALPHA GALACTOSYL CERAMIDES COMPOUNDS | ABIVAX (FR) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291646-A1 | METHOD OF PREPARATION OF ALPHA GALACTOSYL CERAMIDES COMPOUNDS | UGCG, GBA1, MAN2B1 | SSTR5 1126/4885SSTR1 1221/4885SSTR2 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.